GB201502840D0 - Cancer prognostic - Google Patents
Cancer prognosticInfo
- Publication number
- GB201502840D0 GB201502840D0 GB201502840A GB201502840A GB201502840D0 GB 201502840 D0 GB201502840 D0 GB 201502840D0 GB 201502840 A GB201502840 A GB 201502840A GB 201502840 A GB201502840 A GB 201502840A GB 201502840 D0 GB201502840 D0 GB 201502840D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer prognostic
- prognostic
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201502840A GB201502840D0 (en) | 2015-02-20 | 2015-02-20 | Cancer prognostic |
| PCT/GB2016/050357 WO2016132103A1 (en) | 2015-02-20 | 2016-02-15 | Cancer prognostic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201502840A GB201502840D0 (en) | 2015-02-20 | 2015-02-20 | Cancer prognostic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201502840D0 true GB201502840D0 (en) | 2015-04-08 |
Family
ID=52821908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB201502840A Ceased GB201502840D0 (en) | 2015-02-20 | 2015-02-20 | Cancer prognostic |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201502840D0 (en) |
| WO (1) | WO2016132103A1 (en) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7171311B2 (en) * | 2001-06-18 | 2007-01-30 | Rosetta Inpharmatics Llc | Methods of assigning treatment to breast cancer patients |
-
2015
- 2015-02-20 GB GB201502840A patent/GB201502840D0/en not_active Ceased
-
2016
- 2016-02-15 WO PCT/GB2016/050357 patent/WO2016132103A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016132103A1 (en) | 2016-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL255217B (en) | Cancer neoepitopes | |
| GB201420908D0 (en) | Biomarkers | |
| GB201401603D0 (en) | Biomarkers | |
| GB201614455D0 (en) | Biomarkers | |
| ES3048957T3 (en) | Cancer biomarkers | |
| GB201500584D0 (en) | Cancer biomarkers | |
| DK3292140T3 (en) | Immunterapeutikum mod cancer | |
| SG10202007262PA (en) | Copanlisib biomarkers | |
| TWI563730B (en) | Complex antenna | |
| SG10202007322PA (en) | Copanlisib biomarkers | |
| IL254149A0 (en) | Novel therapies for cancer | |
| PT3198034T (en) | Biomarkers for cervical cancer. | |
| GB201508934D0 (en) | Antenna | |
| GB201515664D0 (en) | Antenna | |
| GB201500729D0 (en) | Novel Biomarkers | |
| GB201513692D0 (en) | Antenna | |
| ZA201804206B (en) | Amylose-lipid complexes | |
| GB2546773B (en) | Cancer | |
| GB201508480D0 (en) | Cancer | |
| GB201512133D0 (en) | Biomarkers | |
| GB201521481D0 (en) | Prognostic system | |
| GB201517585D0 (en) | Secure slide | |
| GB201502840D0 (en) | Cancer prognostic | |
| GB201703641D0 (en) | Cancer biomarkers | |
| GB201519704D0 (en) | Biomarkers |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |